# Mini-pool Intravenous Immunoglobulin (MP-IVIG) in Guillain-Barré Syndrome

> **NCT04550611** · NA · UNKNOWN · sponsor: **Assiut University** · enrollment: 50 (estimated)

## Conditions studied

- Guillain-Barre Syndrome

## Interventions

- **OTHER:** Mini-pool Intravenous Immunoglobulin (MP-IVIG)
- **OTHER:** plasma exchange

## Key facts

- **NCT ID:** NCT04550611
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11
- **Primary completion:** 2022-11
- **Final completion:** 2022-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04550611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04550611, "Mini-pool Intravenous Immunoglobulin (MP-IVIG) in Guillain-Barré Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04550611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*